Last Updated : December 1, 2023
Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.
At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.
Draft Recommendations
ibrutinib (Imbruvica)
Therapeutic Area: Waldenström's Macroglobulinemia
Draft recommendations posted for stakeholder feedback: November 30, 2023
End of feedback period: December 14, 2023
Draft Recommendation
calaspargase pegol (TBC)
Therapeutic Area: Acute lymphoblastic leukemia (ALL)
Draft recommendations posted for stakeholder feedback: November 30, 2023
End of feedback period: December 14, 2023
Draft Recommendation
avatrombopag (Doptelet)
Therapeutic Area: Chronic immune thrombocytopenia (ITP)
Draft recommendations posted for stakeholder feedback: November 23, 2023
End of feedback period: December 7, 2023
Open Calls for Patient and Clinician Input
Therapeutic Area
Therapeutic Area:
Ulcerative colitis
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Solid tumours
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Treatment of X-Linked Hypophosphatemia
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Melanoma (Skin)
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Melanoma (Skin)
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Schizophrenia
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Non-small cell lung cancer
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Migraine, prevention
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Therapeutic Area
Therapeutic Area:
Biliary tract carcinoma
Call For Patient Input:
Call For Patient Input:
Patient Input Closed
Patient Input Closed:
Last Updated : December 1, 2023